Adjuvant therapeutic plasma exchange in septic shock
- PMID: 33471132
- PMCID: PMC7816555
- DOI: 10.1007/s00134-020-06339-1
Adjuvant therapeutic plasma exchange in septic shock
Conflict of interest statement
SD has received fees from Baxter for expert advice and talks about plasma exchange in sepsis. SD has received support from Terumo to study plasma exchange in COVID-19, and by the German Research foundation (DA1209/4-3). SD, CB and KS have applied for support of a multicenter RCT from the German Research Foundation (DA1209/6-1). Otherwise, the authors have no conflict of interest related to the topic.
Figures
References
-
- Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018;22:285. doi: 10.1186/s13054-018-2220-9. - DOI - PMC - PubMed
-
- Rimmer E, Houston BL, Kumar A, Abou-Setta AM, Friesen C, Marshall JC, Rock G, Turgeon AF, Cook DJ, Houston DS, Zarychanski R. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care. 2014;18:699. doi: 10.1186/s13054-014-0699-2. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
